Answers are grounded in this paper and cite their sources.
Clinical evaluation examines pharmacist intervention for lipid therapy in peripheral vascular disease, highlighting pathways to improve guideline adherence.
American College of Cardiology/American Heart Association guidelines recommend high-intensity statin therapy and consideration for nonstatin therapy for patients with peripheral vascular disease (PVD); however, utilization rates remain suboptimal. The primary objective of this study was to determine whether pharmacist intervention for patients with PVD could improve the percentage of patients discharged on a high-intensity statin.
No takes yet. Share an insight, caveat, or question.
Tucker et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: